MARKER THERAPEUTICS, INC. Prepaid Expense and Other Assets, Current
MARKER THERAPEUTICS, INC. (MRKR) had Prepaid Expense and Other Assets, Current of $1.04 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-14
- 2026-06-30: Prepaid Expense and Other Assets, Current $1.04M.
- 2026-03-31: Prepaid Expense and Other Assets, Current $418.05K.
- 2025-12-31: Prepaid Expense and Other Assets, Current $658.75K.
- 2025-03-31: Prepaid Expense and Other Assets, Current $841.29K.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2026-06-30 | $1.04M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $418.05K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $658.75K 10-Q · filed 2026-08-14 |
| 2025-03-31 | $841.29K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $483.72K 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |